Shalom Hirschman
Chief Executive Officer bij QUANTRX BIOMEDICAL CORPORATION
Profiel
Shalom Z.
Hirschman is the founder of Xtramedics, Inc., Touro College & University System, and EOM Pharmaceuticals, Inc. He currently holds several positions, including Chairman, Chief Executive & Accounting Officer at QuantRx Biomedical Corp.
since 2010, Chairman at New York Academy of Sciences, Chief Scientific Officer & Medical Director at EOM Pharmaceuticals Holdings, Inc. since 2020, and is a member of various medical associations such as the American Medical Association, American Association for the Advancement of Science, American Society for Microbiology, The Biophysical Society, Harvey Society, American Federation For Clinical Research, and American College of Physicians.
Previously, he served as Professor & Director-Infectious Diseases at The Mount Sinai Hospital, Director-Infectious Diseases Division & Professor at Icahn School of Medicine at Mount Sinai from 1968 to 1997, President, Chief Executive & Scientific Officer at Advanced Viral Research Corp., and Chief Scientific Officer at ImmunoCellular Therapeutics Ltd.
He obtained his doctorate degree from Albert Einstein College of Medicine, Inc.
Actieve functies van Shalom Hirschman
Bedrijven | Functie | Begin |
---|---|---|
QUANTRX BIOMEDICAL CORPORATION | Chief Executive Officer | 31-12-2010 |
EOM PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 27-03-2020 |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Chairman | - |
American Medical Association
American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Harvey Society | Corporate Officer/Principal | - |
American Federation For Clinical Research | Corporate Officer/Principal | - |
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
The Biophysical Society
The Biophysical Society Miscellaneous Commercial ServicesCommercial Services The Biophysical Society specializes in the characterization of molecular structure, measurement of molecular properties, and observation of molecular behavior. The non-profit company is based in Bethesda, MD. The company utilizes a variety of biophysical techniques to study molecules in crystals, solutions, cells, and organisms, providing information about electronic structure, size, shape, dynamics, polarity, and modes of interaction of biological molecules. | Corporate Officer/Principal | - |
American Society for Microbiology
American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Corporate Officer/Principal | - |
░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Eerdere bekende functies van Shalom Hirschman
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░ ░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Opleiding van Shalom Hirschman
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
QUANTRX BIOMEDICAL CORPORATION | Health Technology |
EOM PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 14 |
---|---|
Advanced Viral Research Corp.
Advanced Viral Research Corp. Pharmaceuticals: MajorHealth Technology Advanced Viral Research Corp. is a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. Its products include AVR118, a cytoprotective drug composed of a complex mixture of protein and ribonucleic acid components; AVR123, a form of AVR118 specially designed for dermatology applications, which is in Phase II clinical trials; AVR147, an inhibitor of a cancer target known as a proteasome; AVR168 that is a natural product, which inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. The company was founded in July 1985 and is headquartered in Yonkers, NY. | Health Technology |
American Medical Association
American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Commercial Services |
ImmunoCellular Therapeutics Ltd.
ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Xtramedics, Inc. | Consumer Non-Durables |
The Mount Sinai Hospital
The Mount Sinai Hospital Hospital/Nursing ManagementHealth Services The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY. | Health Services |
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Commercial Services |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
American Society for Microbiology
American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Commercial Services |
The Biophysical Society
The Biophysical Society Miscellaneous Commercial ServicesCommercial Services The Biophysical Society specializes in the characterization of molecular structure, measurement of molecular properties, and observation of molecular behavior. The non-profit company is based in Bethesda, MD. The company utilizes a variety of biophysical techniques to study molecules in crystals, solutions, cells, and organisms, providing information about electronic structure, size, shape, dynamics, polarity, and modes of interaction of biological molecules. | Commercial Services |
Harvey Society | |
American Federation For Clinical Research | |
American College of Physicians
American College of Physicians Miscellaneous Commercial ServicesCommercial Services The American College of Physicians operates as a medical-specialty organization. The non-profit company is based in Philadelphia, PA. Darilyn V. Moyer has been the CEO of the company since 2016. | Commercial Services |
Touro College & University System | |
EOM Pharmaceuticals, Inc.
EOM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of EOM Pharmaceuticals Holdings, Inc., EOM Pharmaceuticals, Inc. is a privately held, clinical-stage company focused on developing novel drugs to improve the quality of life for patients with debilitating and sometimes deadly diseases. The company is based in Montvale, NJ. The company's mission is to pursue innovative approaches with small molecule therapeutics to address urgent and unmet medical needs. EOM's pipeline includes the development of the first-and-only dual-acting, broad-spectrum immunomodulator EOM613, which has the potential to treat systemic illnesses caused by intense inflammatory immune reactions, including COVID-19, influenza, and cancer cachexia. Additionally, EOM is working on an advanced formulation of EOM147, the first potential topically administered eye drop for treating retinal diseases. The company was founded by Shalom Z. Hirschman and Eli Goldberger, and Irach B. Taraporewala has been the CEO since 2020. EOM Pharmaceuticals was acquired by ImmunoCellular Therapeutics Ltd. on December 02, 2021. | Health Technology |